$SNTI 4 SEC Filings

Filed On	Filing
23 Oct 2026	Form 4: Rajangam Kanya, Pres. & Chief Med. & Dev. Off. Gave up 19,953 shares to cover exercise price or tax
23 Oct 2026	Form 4: Lu Timothy K, Director Gave up 157,312 shares to cover exercise price or tax
11 Mar 2026	Form 4: Rajangam Kanya, Pres. & Chief Med. & Dev. Off. Gave up 10,757 shares to cover exercise price or tax
11 Mar 2026	Form 4: Lu Timothy K, Director Gave up 80,666 shares to cover exercise price or tax
03 Feb 2026	Form 4: Rajangam Kanya, Pres. & Chief Med. & Dev. Off. Gave up 1,384 shares to cover exercise price or tax
03 Feb 2026	Form 4: Lu Timothy K, Director Gave up 4,191 shares to cover exercise price or tax
21 Jul 2025	Form 4: Baum Bryan Daniel, Director Granted 43,900 Stock Option (Right to Buy)
27 Jun 2025	Form 4: Collins James J., Director Granted 21,950 Stock Option (Right to Buy)
27 Jun 2025	Form 4: Hsiung Feng, Director Granted 21,950 Stock Option (Right to Buy)
27 Jun 2025	Form 4: Schulz Fran, Director Granted 21,950 Stock Option (Right to Buy)
27 Jun 2025	Form 4: Cooperstone Brenda, Director Granted 21,950 Stock Option (Right to Buy)
27 Jun 2025	Form 4: Tang Donald F, Director Granted 21,950 Stock Option (Right to Buy)
27 Jun 2025	Form 4: Mathers Edward T, Director Granted 21,950 Stock Option (Right to Buy)
14 Mar 2025	Form 4: Celadon Partners Spv 24, 10% owner Received 9,777,000 shares by conversion
12 Mar 2025	Form 4: New Enterprise Associates 15, L.p., 10% owner and 6 others Received 3,333,000 shares by conversion
12 Mar 2025	Form 4: Bayer Healthcare Llc, 10% owner and 3 others Received 2,222,000 shares by conversion
11 Mar 2025	Form 4: Mathers Edward T, Director Granted 43,900 Stock Option (Right to Buy)
11 Mar 2025	Form 4: Rajangam Kanya, Pres. & Chief Med. & Dev. Off. Received 33,000 shares by conversion ($74.3K)
11 Mar 2025	Form 4: Schulz Fran, Director Granted 43,900 Stock Option (Right to Buy)
11 Mar 2025	Form 4: Collins James J., Director Granted 43,900 Stock Option (Right to Buy)

Comments